Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

Abstract Background In 2018, intravenous abatacept was approved for the treatment of refractory polyarticular-course juvenile idiopathic arthritis (JIA) in Japan. However, reports describing the effectiveness and safety of abatacept in clinical practice in Japanese patients with refractory polyartic...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomo Nozawa, Naomi Iwata, Toru Igarashi, Ichiro Kobayashi, Shoji Ota, Takako Yamada, Etsuya Bando, Katsuyoshi Habiro, Syuji Takei
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Polyarticular-course juvenile idiopathic arthritis
Abatacept
Postmarketing surveillance study
Juvenile Arthritis Disease Activity Score 27
Standard deviation score
Growth retardation
Online Access:https://doi.org/10.1186/s12969-025-01069-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12969-025-01069-4

Similar Items